- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Doug Hillblom Discusses Legislative Pushes Toward e-Prescribing
As the capabilities and benefits of e-prescribing become more widely known, states will likely continue enacting requirements to drive the uptake of this new technology, explained Doug Hillblom, PharmD, president at Arena Healthcare, LLC.
As the capabilities and benefits of e-prescribing become more widely known, states will likely continue enacting requirements to drive the uptake of this new technology, explained Doug Hillblom, PharmD, president at Arena Healthcare, LLC.
What state mandates and requirements around e-prescribing have been enacted?
We have states that have enacted mandatory e-prescribing for controlled substances. We have states that are mandating e-prescribing, period. I think this is an environment that’s changing rapidly. You are starting to see, and I include this in e-prescribing, electronic prior authorization being talked about in state legislatures, so I think you will be seeing more and more general adoption.
I think what you’re going to be seeing is that over the course of time, as we gain more experience and states gain more experience, health plans, et cetera, that there’ll be kind of a movement to incorporate as many potential components as possible. If state government doesn’t see things being incorporated as quickly as they would like, they will create a mandate. Often time we see people not implementing things because it’s not mandated, so mandates become part of an implementation concept. “I won’t do it until I have to,” well, now you’re going to have to, and that’s why states are doing so many of these legislative actions.
Are there any misconceptions about e-prescribing you would like to clarify?
E-prescribing in general, one of the things I would like people to think about is, it’s not just initiating and receiving a prescription. There are all kinds of components that we think about as a component of e-prescribing, whether that be prior authorization, whether it be looking at formularies, whether it be looking at refills or refill status or fill status. All of those are things that are part of the whole, shall we say, universe of e-prescribing. I think it’s important for people to think about e-prescribing beyond just being a transaction, but rather a group of interactions between the providers.
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Ways Providers, Payers Can Ensure Biomarker Testing Is Done in Cancer Care
October 18th 2024There is a role for both payers and providers to make small changes that would increase the use of biomarker testing to ensure patients are receiving the appropriate treatment, said Susan Wescott, RPh, MBA, senior director of managed care pharmacy, Mayo Clinic.
Read More
